Back
Dermata Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
DRMA
Dermata Therapeutics
Last Price:
$5.64
Seasonality Move:
-19.85%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight buying pressure.
Dermata Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.23 | Sell |
| 20-day SMA: | 6.59 | Sell |
| 50-day SMA: | 6.74 | Sell |
| 200-day SMA: | 9.94 | Sell |
| 8-day EMA: | 6.22 | Sell |
| 20-day EMA: | 6.47 | Sell |
| 50-day EMA: | 6.88 | Sell |
| 200-day EMA: | 17.31 | Sell |
Dermata Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 41.47 | Sell |
| Chaikin Money Flow: | 2472 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Dermata Therapeutics Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
-
Dermata Therapeutics share price is 5.98 while DRMA 8-day simple moving average is 6.23, which is a Sell signal.
-
The stock price of DRMA is 5.98 while Dermata Therapeutics 20-day SMA is 6.59, which makes it a Sell.
-
Dermata Therapeutics 50-day simple moving average is 6.74 while DRMA share price is 5.98, making it a Sell technically.
-
DRMA stock price is 5.98 and Dermata Therapeutics 200-day simple moving average is 9.94, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
18
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a SellThe current Dermata Therapeutics [DRMA] share price is $5.98. The Score for DRMA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
4.1M
Price in USD:
5.98
Share Volume:
7.4K
Dermata Therapeutics 52-Week Range
52-Week High:
24.90
52-Week Low:
5.74
Sell
18
Dermata Therapeutics (DRMA)
is a Sell
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?The Dermata Therapeutics stock price is 5.98 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is overvalued.
Is Dermata Therapeutics Stock a Buy?
-
Dermata Therapeutics share price is 5.98 while DRMA 8-day exponential moving average is 6.22, which is a Sell signal.
-
The stock price of DRMA is 5.98 while Dermata Therapeutics 20-day EMA is 6.47, which makes it a Sell.
-
Dermata Therapeutics 50-day exponential moving average is 6.88 while DRMA share price is 5.98, making it a Sell technically.
-
DRMA stock price is 5.98 and Dermata Therapeutics 200-day simple moving average is 17.31, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Dermata Therapeutics is a Sell
-
Dermata Therapeutics Relative Strength Index (RSI) is 41.47, which suggest Dermata Therapeutics is oversold
-
The Bollinger Bands (25) for Dermata Therapeutics is ( - ), which suggest Dermata Therapeutics is a Buy
-
The Bollinger Bands (100) for Dermata Therapeutics is ( - ), which suggest Dermata Therapeutics is a Buy
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.